GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AegirBio AB (GREY:AEGBF) » Definitions » Other Long Term Assets

AegirBio AB (AegirBio AB) Other Long Term Assets : $0.02 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is AegirBio AB Other Long Term Assets?

AegirBio AB's other long-term assets for the quarter that ended in Mar. 2024 was $0.02 Mil.

AegirBio AB's quarterly other long-term assets declined from Sep. 2023 ($0.03 Mil) to Dec. 2023 ($0.03 Mil) but then stayed the same from Dec. 2023 ($0.03 Mil) to Mar. 2024 ($0.02 Mil).

AegirBio AB's annual other long-term assets declined from Dec. 2021 ($0.03 Mil) to Dec. 2022 ($0.03 Mil) but then increased from Dec. 2022 ($0.03 Mil) to Dec. 2023 ($0.03 Mil).


AegirBio AB Other Long Term Assets Historical Data

The historical data trend for AegirBio AB's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AegirBio AB Other Long Term Assets Chart

AegirBio AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
- - 0.03 0.03 0.03

AegirBio AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.73 - 0.03 0.03 0.02

AegirBio AB Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


AegirBio AB (AegirBio AB) Business Description

Traded in Other Exchanges
Address
Scheelevagen 27, Lund, SWE, SE-223 63
AegirBio AB is a Swedish diagnostic company that offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. The company's products include Monator - drug monitoring of tysabri in MS, Veritope, and Magniareader.

AegirBio AB (AegirBio AB) Headlines

No Headlines